HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,566.00
+4.00 (0.26%)
At close: Jun 9, 2025, 3:30 PM KST

HLB bioStep Revenue

HLB bioStep had revenue of 13.58B KRW in the quarter ending March 31, 2025, with 17.39% growth. This brings the company's revenue in the last twelve months to 60.18B, up 18.96% year-over-year. In the year 2024, HLB bioStep had annual revenue of 58.17B with 10.14% growth.

Revenue (ttm)
60.18B
Revenue Growth
+18.96%
P/S Ratio
2.28
Revenue / Employee
401.20M
Employees
150
Market Cap
137.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202458.17B5.35B10.14%
Dec 31, 202352.81B-33.46B-38.79%
Dec 31, 202286.28B21.87B33.96%
Dec 31, 202164.40B5.88B10.05%
Dec 31, 202058.52B12.48B27.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
Samsung Biologics 4,898.69B
LG Energy Solution 25.76T
Hyundai Motor Company 178.98T
Hanwha Aerospace 15.28T
Kia Corporation 109.25T
KB Financial Group 14.93T
Revenue Rankings